How inflammation skews the kynurenine pathway — and how ketamine and NAD+ therapy may protect and restore mental health & energy.

Pain Reprocessing Therapy retrains the brain to interpret pain differently. Learn its origins, research, and why we believe in it.

Science-based ADHD focus guide from Huberman Lab: meds, OTC supplements, and behavioral tools to improve attention and focus.

Takeaways & insights from Glennon Doyle’s most recent book, We Can Do Hard Things.

A conversation with Claudia from the Longevity & Lifestyle Podcast about medical cannabis, ketamine therapy, chronic pain, and more.

This real-world study looked at how ketamine impacts people with both PTSD and depression—two conditions that often occur together and make each other harder to treat.

A conversation on healing, psychedelics, and leaving traditional medicine—with insights for both patients and physicians.

Love eases pain. This research review of 20+ studies explores how connection amplifies healing—emotionally and physically..

Honor the future you — self‑discipline is not a punishment, but rather a gift and a show of respect to future you.

A large study links pain in multiple body areas to much higher depression risk. Learn how inflammation and lifestyle matter.

How JournalSpeak can uncover hidden stress and chronic pain triggers through expressive writing for emotional freedom and better health.

How Managers, Firefighters, and Exiles work together to shape your mind and behaviors - and how to work with them. A review of the Huberman Lab podcast featuring IFS founder Dr. Schwartz.

Explore how brain insulin resistance may underlie Alzheimer’s, linking metabolic dysfunction to cognitive decline.

Discover the potential of microdosing GLP-1 for weight loss, inflammation, cognitive health, and more.

How vagus nerve stimulation (VNS) offers relief for conditions like depression, chronic pain, and inflammation with fewer side effects.

According to research, dance and other forms of exercise are more effective than medications like SSRIs in reducing depression symptoms.

GLP-1 receptor agonists show promise in Alzheimer’s disease prevention, offering benefits beyond weight loss and diabetes management.

Explore top insights from A4M’s Longevity Conference, including neurotransmitter health, vagus nerve stimulation, GLP-1 therapy, and cellular longevity.

Research review: how a two-week social media detox can reduce stress, improve sleep, and foster healthier habits.